Clinical Trials Browser

Phase 2 × Leukopenia × 90 days × Clear all

NCT07380646 2026-02-02

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Leukopenia, Neutropenia